COMMUNIQUÉS West-GlobeNewswire

Novartis announces JAMA Cardiology publication of data showing Entresto® improves physical and social activity in HFrEF patients versus enalapril

04/04/2018 - 17:00

Post-hoc analysis of PARADIGM-HF published in JAMA Cardiology shows heart failure patients treated with Entresto experience significant improvements in physical and social activities compared to those taking enalapril[1 [...]

C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna through Varian Medical Systems

04/04/2018 - 16:30

C-RAD announced today orders from Varian Medical Systems to equip Nya Karolinska Solna (NKS), Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution. The contract includes the supply of C-RAD’s [...]

BioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber

04/04/2018 - 16:28

Pompano Beach, FL, April 04, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]

Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018

04/04/2018 - 16:00

CINCINNATI, April 04, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading diagnostic and life science component company, expects to release its second quarter fiscal 2018 operating results [...]

Tower One Provides Warrant Incentive Program Update

04/04/2018 - 15:27

VANCOUVER, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces the mechanism by which warrants can be executed [...]

Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018

04/04/2018 - 15:00

GR-MD-02 treatment in NASH cirrhosis patients without esophageal varices shows statistically significant and clinically meaningful effects NORCROSS, Ga., April 04, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. ( [...]

Green Cures & Botanical Distribution Announce a Company Update

04/04/2018 - 15:00

LOS ANGELES, CA, April 04, 2018 (GLOBE NEWSWIRE) -- Green Cures (OTC PINK: GRCU) is happy to announce the expansion of our Corporate Offices into a brand new dynamic space nestled in Woodland Hills California. Here we [...]

CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules

04/04/2018 - 14:57

LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE has a competitive [...]

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

04/04/2018 - 14:45

Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has [...]

MJ Biotech, Inc Announces $428,000 in First Quarters Sales

04/04/2018 - 14:45

CHEYENNE, Wyo., April 04, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) Zen’s Tea House, sales results for March 2018 were just over $168,000; combining that with the January [...]

Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

04/04/2018 - 14:30

MINNEAPOLIS, April 04, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]

MyoKardia Announces Appointment of Taylor C. Harris as Chief Financial Officer

04/04/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Hemispherx Expands Ampligen Early Access Programme to Canada to Treat ME/CFS Patients

04/04/2018 - 14:30

Early Access Programs are Known as “Special Access Programme” in Canada ORLANDO, Fla., April 04, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, said it [...]

Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/04/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that on March 29, 2018, the Compensation Committee of the Board of Directors approved, [...]

SteroTherapeutics Receives FDA Orphan-Drug Designation

04/04/2018 - 14:00

PHILADELPHIA, April 04, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing therapies focused on metabolic diseases including non-alcoholic steatohepatitis (NASH), announced [...]

Trinitas-St. Joseph’s Behavioral Health Network Offers Innovative Alternative Treatment for Depression

04/04/2018 - 14:00

Transcranial Magnetic Stimulation (TMS) helps adult patients with depression who have not benefited from initial antidepressant medication therapies PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. [...]

CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference

04/04/2018 - 14:00

SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Rezolute Announces Appointment of Hoyoung Huh, M.D., Ph.D. as Vice Chairman of its Board of Directors

04/04/2018 - 14:00

LOUISVILLE, Colo., April 04, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]

Cellectar Biosciences Appoints Brian M. Posner as Chief Financial Officer

04/04/2018 - 14:00

MADISON, Wis., April 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]